Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels - An analysis within the COLOFOL randomized clinical trial

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prehabilitation in surgery - Need for new strategies?

    Research output: Contribution to journalEditorialResearchpeer-review

  2. Missed opportunities and challenges for surgical breast cancer research in the era of personalized cancer treatment

    Research output: Contribution to journalEditorialResearchpeer-review

  3. Near-infrared fluorescence imaging improves the nodal yield in neck dissection in oral cavity cancer - A randomized study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Tomografía computarizada para el diagnóstico de la apendicitis aguda en adultos

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Computed tomography for diagnosis of acute appendicitis in adults

    Research output: Contribution to journalReviewResearchpeer-review

  3. Local recurrence rate in a national Danish patient cohort after curative treatment for rectal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Patients with colorectal cancer were examined to determine (1) whether elevated carcinoembryonic antigen (CEA) levels, either before treatment or after surgery, was associated with an increased risk of overall or colorectal cancer-specific mortality or recurrence, and (2) whether high intensity follow-up would benefit those patients.

MATERIALS AND METHODS: Post-hoc analysis based on 2509 patients that underwent surgery for colorectal cancer, stage II or III, in the COLOFOL randomized trial with 5-year follow-up. Serum CEA levels were ascertained before treatment and one month after surgery. Follow-up examinations included computed tomography of the thorax and abdomen and serum CEA sampling. Patients were randomized to examinations at either 6, 12, 18, 24, and 36 months (high-intensity group) or at 12 and 36 months after surgery (low-intensity group). Levels of CEA >5 μg/l were defined as elevated.

RESULTS: Elevated CEA levels before treatment were associated with increased risk of recurrence (hazard ratio [HR], 1.49; 95% confidence interval [CI]: 1.22-1.83), colorectal cancer-specific mortality (HR, 1.44; 95% CI: 1.08-1.91), and overall mortality (HR, 1.38; 95% CI: 1.07-1.78). Elevated CEA levels after surgery were associated with increased colorectal cancer-specific mortality (HR, 1.68; 95% CI: 1.08-2.61) and overall mortality (HR, 1.79; 95% CI: 1.22-2.63). The intensity of the follow-up regimen had no effect on 5-year outcomes in patients with elevated CEA levels.

CONCLUSION: Both pre-treatment and post-surgery elevated serum CEA levels were associated with increased overall and cancer-specific mortality. Intensified follow-up showed no benefit over low-intensity follow-up in this high-risk group of patients with elevated CEA levels.

Original languageEnglish
JournalEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Volume47
Issue number8
Pages (from-to)2053-2059
Number of pages7
ISSN0748-7983
DOIs
Publication statusPublished - Aug 2021

    Research areas

  • Carcinoembryonic antigen, Clinical trial, Colorectal cancer, Follow-up, Post-hoc analysis

ID: 66403907